| #134 |
Paulo Andre Nobrega Marinho |
University of California |
1 |
| #134 |
Shami Joseph Baudichon |
— |
1 |
| #134 |
Pierre Steiner |
Bsh Hausgeräte Gmbh |
1 |
| #134 |
Jole Sole |
Thomson Licensing |
1 |
| #134 |
Seth M. Pransky |
Arthrocare |
1 |
| #134 |
Lufen Chang |
Stembios Technologies |
1 |
| #134 |
Kiarash Kiantaj |
University of California |
1 |
| #134 |
Jim Oates |
Avago Technologies General Ip (Singapore) Pte. |
1 |
| #134 |
Muchuan Yang |
University of California |
1 |
| #134 |
Rafael Cosman |
Palantir Technologies |
1 |
| #134 |
Douglas Bates |
Rheem Manufacturing |
1 |
| #134 |
Amalio Telenti |
Ecole Polytechnique Federale De Lausanne (Epfl) |
1 |
| #134 |
Brian J. Keefe |
— |
1 |
| #134 |
Ulf Carl Mikael Setterberg |
Maxwell Technologies |
1 |
| #134 |
Juliesta Elaine Sylvester |
Molecular Assemblies |
1 |
| #134 |
Alan Grubbs |
Molecular Assemblies |
1 |
| #134 |
Philip Low |
— |
1 |
| #134 |
Marc R. Montminy |
Salk Institute For Biological Studies |
1 |
| #134 |
Charlie Gunderson |
Drivecam |
1 |
| #134 |
Alex Battaglia |
— |
1 |
| #134 |
Robert C. Dynes |
University of California |
1 |
| #134 |
Mitul Shah |
Bank of America |
1 |
| #134 |
Robert Clarke |
Asi Group |
1 |
| #134 |
Paul D. van Poelje |
Metabasis Therapeutics |
1 |
| #134 |
Peter L. Nguy |
Inhibrx |
1 |
| #134 |
Peter Andrew Smith |
Rqx Pharmaceuticals |
1 |
| #134 |
Victor Bronshtein |
Comcast |
1 |
| #134 |
Osman Kibar |
Biosplice Therapeutics |
1 |